Group 1 - Shengxin Lithium Energy plans to acquire 21% stake in Qicheng Mining for 1.456 billion yuan, increasing its ownership to 70% [4] - Tianpu Co. has seen its stock rise 279.73% over 14 consecutive trading days, but the acquirer Zhonghao Xinying has no asset injection plan [5] - Hangdian Co. reports losses in its optical communication business while its copper foil business is still in the early stages [6][7] Group 2 - Tianchuang Fashion is launching a shareholder reward activity, offering 70% discount coupons to shareholders [8] - Beiliang Co. is collaborating with Tonghuashun to host a "Shareholder Festival" for past investors [9] - Xinxiang Chemical Fiber will undergo a 90-day orderly shutdown for equipment upgrades, affecting 31,200 tons/year capacity and expected revenue loss of approximately 185 million yuan [10] Group 3 - Bozhong Precision plans to transfer 18.29% stake in Suzhou Linghou Robotics for 64 million yuan [11] - Tiancai Self-Control has received a project confirmation from a leading domestic new energy vehicle company for seat assembly, expected to start production in June 2026 [12] - Huazi Industrial's subsidiary plans to sell dairy farm assets for 38.5 million yuan, impacting current profits by approximately 11.7 million yuan [13] Group 4 - Oriental Pearl plans to invest in a special fund to acquire equity in Chaoyuan Digital Technology, committing 244 million yuan [14] - Daotong Technology intends to transfer 46% stake in Shenzhen Saifang Technology for 109 million yuan, focusing on core business development [15] - Lepu Medical has signed a strategic cooperation agreement with Hanhai Information to enhance online sales channels for its aesthetic medicine segment [16] Group 5 - Dingxin Communications clarifies that its technology authorization from Pingtouge is unrelated to AI chip development [17] - Changchuan Technology expects a net profit increase of 131.39% to 145.38% year-on-year for the first three quarters of 2025, driven by strong semiconductor demand [18] Group 6 - Guangdong Construction has won a construction contract worth 1.924 billion yuan for a property reconstruction project [19] - Youxunda is expected to win a procurement project from the State Grid worth approximately 107 million yuan, representing 10.55% of its 2024 revenue [20] - Samsung Medical anticipates winning procurement projects from the State Grid totaling about 193 million yuan [21] Group 7 - Baiyun Electric is a candidate for multiple procurement projects from the State Grid, with a total expected amount of 162 million yuan [22] - *ST Weihe is a candidate for a 141 million yuan engineering project [23] - Plad has signed a strategic cooperation agreement with a well-known international power tool brand for over 700 million yuan in purchases over five years [25] Group 8 - Lanhua Kecai has signed a strategic cooperation agreement with Panhu Power for joint development of axial flux motors [26] - Zhixiang Jintai has entered into commercialization agreements for two monoclonal antibody injections, gaining exclusive rights in various regions [27] - Honggong Technology plans to invest up to 450 million yuan in a project with the Changsha Economic Development Zone [28] Group 9 - Zhejiang Medicine's major shareholder plans to reduce its stake by up to 1% [29] - Su Yan Jingshen's directors plan to collectively increase their holdings by 1.9 to 2.66 million yuan [30] - Zhongdian Electric's shareholder intends to reduce its stake by up to 3% [32] Group 10 - Sanfu New Science plans to repurchase shares worth 10 to 15 million yuan for employee stock incentives [41] - Guiyan Platinum plans to raise up to 1.291 billion yuan for technology innovation and industry upgrades [42] - Zhongjing Electronics plans to raise up to 700 million yuan, with the controlling shareholder participating in the subscription [43]

证券日报网讯 9月22日晚间，乐普医疗发布公告称，近日，公司与汉海信息技术（上海）有限公司（简 称"汉海信息"）签署《战略合作协议》，拟本着平等互利、优势互补的原则，结成长期、全面的战略伙 伴关系，实现资源共享、共同发展。本事项无需提交公司董事会和股东大会审议。 （文章来源：证券日报） ...

Core Viewpoint - Lepu Medical has signed a strategic cooperation agreement with Hanhai Information Technology (Shanghai) Co., Ltd., aiming for a long-term partnership based on mutual benefits and resource sharing [1] Group 1: Strategic Partnership - The agreement establishes a comprehensive strategic partnership between Lepu Medical and Hanhai Information [1] - Hanhai Information is a core entity of Meituan in Shanghai, possessing complete operational rights for Meituan and Dianping [1] Group 2: Market Promotion and Operations - Hanhai Information will be authorized by Lepu Medical to promote and operate the medical beauty segment's brands [1]

Core Viewpoint - Lepu Medical (300003.SZ) has signed a strategic cooperation agreement with Hanhai Information Technology (Shanghai) Co., Ltd. to enhance the marketing and operation of its medical beauty segment brands [1] Group 1: Strategic Cooperation - Hanhai Information will be authorized to promote and operate Lepu Medical's medical beauty brands after receiving company authorization [1] - The cooperation includes deep collaboration on the full-chain marketing of the brands Yuyayan and Flora, covering marketing strategy formulation, sales execution, and after-sales operations [1] Group 2: Hanhai Information's Role - Hanhai Information is the authorized distributor for Yuyayan and Flora products in mainland China and will provide both online and offline operational resources [1] - Hanhai Information is a core entity of Meituan in Shanghai, possessing complete platform operational rights [1]

Core Viewpoint - Lepu Medical (300003.SZ) has signed a strategic cooperation agreement with Hanhai Information Technology (Shanghai) Co., Ltd. for the marketing and operation of its medical beauty segment brands [1] Group 1: Strategic Cooperation - Hanhai Information will have the authority to promote and operate Lepu Medical's medical beauty brands after receiving authorization from the company [1] - The cooperation includes deep collaboration on the full-chain marketing of the products Yuyayan and Flora, covering marketing strategy formulation, sales execution, and after-sales operations [1] Group 2: Hanhai Information's Role - Hanhai Information is the authorized distributor for Lepu Medical's Yuyayan and Flora products in mainland China [1] - Hanhai Information is a core entity of Meituan in Shanghai, possessing complete operational rights on platforms like Meituan and Dianping [1]

Core Viewpoint - The company, Lepu Medical (300003.SZ), has signed a strategic cooperation agreement with Hanhai Information Technology (Shanghai) Co., Ltd. to establish a long-term partnership focused on resource sharing and mutual development [1][2]. Group 1: Strategic Partnership - The agreement aims to create a comprehensive strategic partnership based on equality and mutual benefit [1][2]. - Hanhai Information will have the authority to promote and operate the company's medical beauty brands after receiving authorization [2]. - The partnership will leverage Hanhai Information's online and offline resources to provide a comprehensive marketing plan for the brands Yuyayan and Flora [2]. Group 2: Marketing and Sales Strategy - Both parties will collaborate on the full-chain marketing of Yuyayan and Flora products, including strategy formulation, sales execution, and after-sales operations [2]. - The cooperation will enhance the company's sales channels by adding online collaboration to existing offline sales channels, creating an omnichannel sales network [2]. - Future cooperation may extend to other products under the company's brand, subject to mutual agreement [2]. Group 3: Impact on Business Performance - The immediate impact of the agreement on the company's operating performance is uncertain; however, it may positively influence future annual performance as the cooperation progresses [2].

Core Viewpoint - The company has signed a strategic cooperation agreement with Hanhai Information Technology (Shanghai) Co., Ltd. to establish a long-term partnership focused on resource sharing and mutual development [1][2]. Group 1: Partnership Details - Hanhai Information will have the authority to promote and operate the company's medical beauty brands after receiving company authorization [2]. - Hanhai Information is the distributor for the company's Yuyayan and Flora products in mainland China, providing both online and offline operational solutions [2]. - The collaboration will involve deep coordination on the full-chain marketing of Yuyayan and Flora products, including strategy formulation, sales execution, and after-sales operations [2]. Group 2: Strategic Implications - The partnership aims to enhance the company's medical beauty business by adding online sales channels that complement existing offline channels [2]. - The signing of the strategic cooperation agreement may have uncertain impacts on the company's current operating performance, but could positively influence future annual performance as the collaboration progresses [2].

Core Viewpoint - Lepu Medical (300003.SZ) has signed a strategic cooperation agreement with Hanhai Information Technology (Shanghai) Co., Ltd, aiming to establish a long-term and comprehensive partnership to develop the medical aesthetics business sector [1] Company Summary - The partnership will enable Hanhai Information to promote and operate the brands under Lepu Medical's medical aesthetics segment, providing both online and offline operational solutions [1] - This collaboration is expected to create new online sales channels for Lepu Medical's medical aesthetics segment, complementing existing offline sales channels and building an omnichannel sales network [1] Industry Summary - Hanhai Information is a core entity of Meituan in Shanghai, legally operating Meituan and Dianping, and possesses complete platform operational rights [1]

人民财讯9月22日电，乐普医疗（300003）9月22日公告，近日，公司与汉海信息技术(上海)有限公司(简 称"汉海信息")签署战略合作协议，拟结成长期、全面的战略伙伴关系，实现资源共享、共同发展。此 次合作将为公司医美板块销售新增线上合作渠道，与现有线下销售渠道形成互补，构建全渠道销售网 络。 ...

每经头条（nbdtoutiao）——始祖鸟深陷"炸山"风波，母公司大中华区新总裁上任才两个多月，被赞"专 业能力深厚"！安踏体育最新回应→ （记者 王晓波） 每经AI快讯，乐普医疗（SZ 300003，收盘价：18.04元）9月22日晚间发布公告称，近日，乐普医疗器 械股份有限公司与汉海信息技术（上海）有限公司签署《战略合作协议》，拟本着平等互利、优势互补 的原则，结成长期、全面的战略伙伴关系，实现资源共享、共同发展。根据《深圳证券交易所股票上市 规则》及《公司章程》的规定，本次战略合作协议的签署不涉及具体交易金额和交易事项，不构成关联 交易，也不构成重大资产重组，无需提交公司董事会和股东大会审议。公司将根据后续合作的进展情况 依规履行必要的审批程序和信息披露义务。 2025年1至6月份，乐普医疗的营业收入构成为：医疗器械占比52.72%，药品占比33.16%，医疗服务及 健康管理占比14.11%。 截至发稿，乐普医疗市值为339亿元。 ...